ClinicalTrials.Veeva

Menu

Endogenous Lithium Clearance in Acute Kidney Injury

U

University Hospital of North Norway

Status

Completed

Conditions

Acute Kidney Injury Due to Sepsis
Proximal Tubule Function
Lithium Clearance

Treatments

Diagnostic Test: Lithium clearance

Study type

Observational

Funder types

Other

Identifiers

NCT05982340
03055 PVO

Details and patient eligibility

About

Critically ill patients are at high risk of developing acute kidney injury (AKI). Lithium is freely filtrated at the glomerulus and almost completely reabsorbed in the proximal tubule, which provides a quantitative estimation of proximal tubule reabsorption. The investigators hypothesized that endogenous lithium reabsorption is impaired in the early stages of critical illness.

Investigators would like to study 10 ICU patients with AKI diagnosed, 10 patients without AKI, and 10 healthy controls.

Full description

Blood and urine samples will be obtained at 08:00, 14:00 and 20:00 during one day. Renal clearance of creatinine (CCr) and lithium will be calculated.

Enrollment

20 patients

Sex

All

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • ICU patients diagnosed with AKI, without AKI and healthy controls

Exclusion criteria

Trial design

20 participants in 2 patient groups

Group 1
Description:
ICU patients with AKI
Treatment:
Diagnostic Test: Lithium clearance
Group 2
Description:
ICU patients with normal renal function
Treatment:
Diagnostic Test: Lithium clearance

Trial contacts and locations

1

Loading...

Central trial contact

Lars Marius Ytrebø

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems